http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AT-231068-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac40ffdd0f9b7563bab9d5dccaa8a6b3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-60
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0018
filingDate 1961-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1964-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1964-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AT-231068-B
titleOfInvention Process for the manufacture of vaccine intermediates
priorityDate 1960-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581064
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407832258
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11953884
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID769

Total number of triples: 16.